Drug: |
Dovitinib |
|||
---|---|---|---|---|
Trial: |
Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
Sarcoma Oncology Center2811 Wilshire Blvd Suite 414 |
Principal Investigator: |
Sant Chawla, MD |
---|---|
Contact: |
(310) 552-9999 santchawla@sarcomaoncology.com |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Sarcoma Oncology Center Website: |
http://www.sarcomaoncology.com/ReserchStudies/Clinicaltrials.htm |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.